Literature DB >> 29746302

LDL and foam cell formation as the basis of atherogenesis.

Alexander N Orekhov1,2.   

Abstract

PURPOSE OF REVIEW: Lipoprotein-induced intracellular lipid accumulation (foam cell formation) is a trigger of atherogenesis at the subendothelial arterial cell level. The purpose of this review is to describe the recent data related to the possible mechanisms of LDL-induced formation of lipid-laden foam cells and their role in the onset and development of atherosclerotic lesion. RECENT
FINDINGS: The most interesting current studies are related to the factors affecting foam cell formation.
SUMMARY: The phenomenon of lipid accumulation in cultured cells became the basis for creating a cellular test system that has already been successfully applied for development of drugs possessing direct antiatherosclerotic activity, and then the efficacy of these drugs was demonstrated in clinical studies. Moreover, this test system could be used for diagnostic assessing lipoproteins atherogenicity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29746302     DOI: 10.1097/MOL.0000000000000525

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  14 in total

1.  APE1 inhibits foam cell formation from macrophages via LOX1 suppression.

Authors:  Zhaohui Hu; Bo Hui; Xuwei Hou; Ruhui Liu; Sergiy Sukhanov; Xiaohong Liu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 2.  Atherosclerosis: integration of its pathogenesis as a self-perpetuating propagating inflammation: a review.

Authors:  Robin N Poston
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15

Review 3.  Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor: Mechanistic Insight and Potential Clinical Use.

Authors:  Joaquim Barreto; Sotirios K Karathanasis; Alan Remaley; Andrei C Sposito
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-11-12       Impact factor: 10.514

4.  Salvianolic Acid A Ameliorates Early-Stage Atherosclerosis Development by Inhibiting NLRP3 Inflammasome Activation in Zucker Diabetic Fatty Rats.

Authors:  Quanxin Ma; Qinqin Yang; Jiaojiao Chen; Chen Yu; Lizong Zhang; Weimin Zhou; Minli Chen
Journal:  Molecules       Date:  2020-02-28       Impact factor: 4.411

Review 5.  Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis.

Authors:  Anastasia V Poznyak; Wei-Kai Wu; Alexandra A Melnichenko; Reinhard Wetzker; Vasily Sukhorukov; Alexander M Markin; Victoria A Khotina; Alexander N Orekhov
Journal:  Cells       Date:  2020-03-01       Impact factor: 6.600

6.  Role of Phagocytosis in the Pro-Inflammatory Response in LDL-Induced Foam Cell Formation; a Transcriptome Analysis.

Authors:  Alexander N Orekhov; Nikita G Nikiforov; Vasily N Sukhorukov; Marina V Kubekina; Igor A Sobenin; Wei-Kai Wu; Kathy K Foxx; Sergey Pintus; Philip Stegmaier; Daria Stelmashenko; Alexander Kel; Alexei N Gratchev; Alexandra A Melnichenko; Reinhard Wetzker; Volha I Summerhill; Ichiro Manabe; Yumiko Oishi
Journal:  Int J Mol Sci       Date:  2020-01-27       Impact factor: 5.923

Review 7.  Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review.

Authors:  Xiaona Chen; Yanhong He; Wenjun Fu; Amirhossein Sahebkar; Yuhui Tan; Suowen Xu; Hong Li
Journal:  Front Cell Dev Biol       Date:  2020-11-12

Review 8.  Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis.

Authors:  Anastasia V Poznyak; Nikita G Nikiforov; Alexander M Markin; Dmitry A Kashirskikh; Veronika A Myasoedova; Elena V Gerasimova; Alexander N Orekhov
Journal:  Front Pharmacol       Date:  2021-01-11       Impact factor: 5.810

9.  Signaling Pathways Potentially Responsible for Foam Cell Formation: Cholesterol Accumulation or Inflammatory Response-What is First?

Authors:  Alexander N Orekhov; Vasily N Sukhorukov; Nikita G Nikiforov; Marina V Kubekina; Igor A Sobenin; Kathy K Foxx; Sergey Pintus; Philip Stegmaier; Daria Stelmashenko; Alexander Kel; Anastasia V Poznyak; Wei-Kai Wu; Artem S Kasianov; Vsevolod Y Makeev; Ichiro Manabe; Yumiko Oishi
Journal:  Int J Mol Sci       Date:  2020-04-14       Impact factor: 5.923

10.  Mangiferin promotes macrophage cholesterol efflux and protects against atherosclerosis by augmenting the expression of ABCA1 and ABCG1.

Authors:  Kun Ren; Heng Li; Hui-Fang Zhou; Yin Liang; Min Tong; Lu Chen; Xi-Long Zheng; Guo-Jun Zhao
Journal:  Aging (Albany NY)       Date:  2019-12-02       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.